SynthesisEuropean journal of clinical pharmacology2026

Outcomes for metastatic triple-negative breast cancer patients treated with sacituzumab govitecan in clinical studies and real-world studies: a single-arm meta-analysis.

Shuang Liang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.